$GTCB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in rEVO Biologics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in rEVO Biologics, Inc.. Get notifications about new insider transactions in rEVO Biologics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13 2004 | GTCB | rEVO Biologics, In ... | LANDINE MICHAEL J | Director | Option Exercise | A | 1.50 | 22,500 | 33,750 | 22,500 | |
| Dec 13 2004 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 2.25 | 1,000 | 2,250 | 1,000 | |
| Dec 13 2004 | GTCB | rEVO Biologics, In ... | Bauer Kenneth | Director | Option Exercise | A | 1.50 | 15,000 | 22,500 | 15,000 | |
| Dec 13 2004 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | SVP and General Cou ... | Option Exercise | A | 2.25 | 1,000 | 2,250 | 1,000 | |
| Dec 13 2004 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | SVP and General Cou ... | Option Exercise | A | 2.25 | 1,000 | 2,250 | 1,000 | |
| Dec 13 2004 | GTCB | rEVO Biologics, In ... | MEADE HARRY | SVP, Transgenic Res ... | Option Exercise | A | 2.25 | 1,000 | 2,250 | 1,000 | |
| Dec 13 2004 | GTCB | rEVO Biologics, In ... | LIPOSKY GREGORY F | SVP, Operations | Option Exercise | A | 2.25 | 1,000 | 2,250 | 1,000 | |
| Dec 13 2004 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | SVP and CFO | Option Exercise | A | 2.25 | 1,000 | 2,250 | 1,000 | |
| Dec 13 2004 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | SVP and CFO | Option Exercise | A | 2.25 | 1,000 | 2,250 | 1,000 | |
| Oct 13 2004 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | SVP and General Cou ... | Buy | J | 1.31 | 404 | 529 | 30,423 | 30 K to 30.4 K (+1.35 %) |
| Oct 13 2004 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 1.31 | 741 | 971 | 65,551 | 64.8 K to 65.6 K (+1.14 %) |
| Jul 13 2004 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | SVP and General Cou ... | Buy | J | 1.70 | 1,243 | 2,113 | 30,019 | 28.8 K to 30 K (+4.32 %) |
| Jul 13 2004 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 1.70 | 761 | 1,294 | 64,810 | 64 K to 64.8 K (+1.19 %) |
| May 28 2004 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Option Exercise | A | 1.75 | 22,500 | 39,375 | 22,500 | |
| May 28 2004 | GTCB | rEVO Biologics, In ... | BALDRIDGE ROBERT W | Director | Option Exercise | A | 1.75 | 22,500 | 39,375 | 22,500 | |
| May 12 2004 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 1.85 | 400 | 740 | 2,000 | 1.6 K to 2 K (+25.00 %) |
| May 12 2004 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 1.84 | 100 | 184 | 1,600 | 1.5 K to 1.6 K (+6.67 %) |
| May 12 2004 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 1.83 | 1,500 | 2,745 | 1,500 | 0 to 1.5 K |
| Apr 12 2004 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | SVP and General Cou ... | Buy | J | 2.20 | 841 | 1,851 | 28,776 | 27.9 K to 28.8 K (+3.01 %) |
| Apr 12 2004 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Buy | J | 2.20 | 513 | 1,129 | 64,049 | 63.5 K to 64 K (+0.81 %) |
| Mar 19 2004 | GTCB | rEVO Biologics, In ... | GERAGHTY JAMES A | Director | Grant | A | 2.14 | 1,000 | 2,141 | 51,791 | 50.8 K to 51.8 K (+1.97 %) |
| Mar 19 2004 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | Chairman, President ... | Grant | A | 2.15 | 1,700 | 3,655 | 63,536 | 61.8 K to 63.5 K (+2.75 %) |
| Mar 19 2004 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | Chairman, President ... | Grant | A | 2.16 | 600 | 1,296 | 61,836 | 61.2 K to 61.8 K (+0.98 %) |
| Mar 19 2004 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | Chairman, President ... | Grant | A | 2.15 | 1,700 | 3,655 | 63,536 | 61.8 K to 63.5 K (+2.75 %) |
| Mar 19 2004 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | Chairman, President ... | Grant | A | 2.16 | 600 | 1,296 | 61,836 | 61.2 K to 61.8 K (+0.98 %) |
| Feb 18 2004 | GTCB | rEVO Biologics, In ... | GREEN JOHN B | Senior Vice Preside ... | Option Exercise | A | 3.96 | 25,000 | 99,000 | 25,000 | |
| Feb 18 2004 | GTCB | rEVO Biologics, In ... | LIPOSKY GREGORY F | SVP, Operations | Option Exercise | A | 3.96 | 35,000 | 138,600 | 35,000 | |
| Feb 18 2004 | GTCB | rEVO Biologics, In ... | COX GEOFFREY F | President, CEO and ... | Option Exercise | A | 3.96 | 75,000 | 297,000 | 75,000 | |
| Feb 18 2004 | GTCB | rEVO Biologics, In ... | WOLOSHEN DANIEL S | SVP and General Cou ... | Option Exercise | A | 3.96 | 25,000 | 99,000 | 25,000 | |
| Feb 18 2004 | GTCB | rEVO Biologics, In ... | MEADE HARRY | SVP, Transgenic Res ... | Option Exercise | A | 3.96 | 25,000 | 99,000 | 25,000 | |
| Aug 20 2003 | GTCB | rEVO Biologics, In ... | MCNAMARA PAMELA W | Director | Buy | P | 2.56 | 3,800 | 9,728 | 3,800 | 0 to 3.8 K |